UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 297

Sortiert nach

Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions

Blood, 2006-05, Vol.107 (9), p.3436-3441

Neufeld, Ellis J.

2006

Volltextzugriff (PDF)

Erythrocyte pyruvate kinase deficiency: 2015 status report

American journal of hematology, 2015-09, Vol.90 (9), p.825-830

2015

Volltextzugriff (PDF)

Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study

Haematologica (Roma), 2019-02, Vol.104 (2), p.e51

2019

Volltextzugriff (PDF)

Pediatric Heparin-Induced Thrombocytopenia: Prevalence, Thrombotic Risk, and Application of the 4Ts Scoring System

The Journal of pediatrics, 2015-01, Vol.166 (1), p.144-150.e1

2015

Volltextzugriff (PDF)

Safety update on the use of recombinant activated factor VII in approved indications

Blood reviews, 2015-06, Vol.29, p.S34-S41

2015

Volltextzugriff (PDF)

Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol

BMJ open, 2021-08, Vol.11 (8), p.e044885

2021

Volltextzugriff (PDF)

Systematic molecular genetic analysis of congenital sideroblastic anemia: Evidence for genetic heterogeneity and identification of novel mutations

Pediatric blood & cancer, 2010-02, Vol.54 (2), p.273-278

2010

Volltextzugriff (PDF)

Risk of Post-Procedural Bleeding in Children on Intravenous Fish Oil

The American journal of surgery, 2017-10, Vol.214 (4), p.733-737

2017

Volltextzugriff (PDF)

Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion

The Journal of thoracic and cardiovascular surgery, 2009-04, Vol.137 (4), p.934-941

2009

Volltextzugriff (PDF)

Novel therapeutics and future directions for refractory immune thrombocytopenia

British journal of haematology, 2023-10, Vol.203 (1), p.65-78

2023

Volltextzugriff (PDF)

Does iron overload really matter in stem cell transplantation?

American journal of hematology, 2012-06, Vol.87 (6), p.569-572

2012

Volltextzugriff (PDF)

X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation

Blood, 2007-04, Vol.109 (8), p.3297-3299

2007

Volltextzugriff (PDF)

Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families: Observations from the Dosing Observational Study in Hemophilia

Value in health, 2012-09, Vol.15 (6), p.916-925

2012

Volltextzugriff (PDF)

Inadequate Dietary Intake in Patients with Thalassemia

Journal of the Academy of Nutrition and Dietetics, 2012-07, Vol.112 (7), p.980-990

2012

Volltextzugriff (PDF)

Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension

Haematologica (Roma), 2013-09, Vol.98 (9), p.1359-1367

2013

Volltextzugriff (PDF)

Treatment with Rituximab in Benign and Malignant Hematologic Disorders in Children

The Journal of pediatrics, 2007-04, Vol.150 (4), p.338-344.e1

2007

Volltextzugriff (PDF)

MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients

American journal of hematology, 2014-07, Vol.89 (7), p.684-688

2014

Volltextzugriff (PDF)

Beliefs about chelation among thalassemia patients

Health and quality of life outcomes, 2012-12, Vol.10 (1), p.148-148

2012

Volltextzugriff (PDF)

Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Observational Study in Hemophilia (DOSE)

Value in health, 2014-09, Vol.17 (6), p.744-748

2014

Volltextzugriff (PDF)

Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP

Blood, 2015-08, Vol.126 (7), p.873-879

2015

Volltextzugriff (PDF)

A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload

Haematologica (Roma), 2011-04, Vol.96 (4), p.521-525

2011

Volltextzugriff (PDF)

Skin Testing, Graded Challenge and Desensitization to Von Willebrand Factor (vWF) Products in Type III Von Willebrand Disease (VWD)

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB121-AB121

2015

Volltextzugriff (PDF)

Inflammation and oxidant-stress in β-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine : an ancillary study of the Novartis CICL670A0107 trial

Haematologica (Roma), 2008-06, Vol.93 (6), p.817-825

2008

Volltextzugriff (PDF)

Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results

Magnetic resonance imaging, 2015-07, Vol.33 (6), p.761-767

2015

Volltextzugriff (PDF)

Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)

Transfusion (Philadelphia, Pa.), 2014-04, Vol.54 (4), p.972-981

2014

Volltextzugriff (PDF)

1 – 25 von 297

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(288)
Mit Volltextzugriff
(275)

Publikationsform

Sprache

Englisch
(296)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(177)
Life Sciences & Biomedicine
(175)
Humans
(157)
Male
(105)
Hematology
(102)
Female
(100)
Child
(81)
Biological And Medical Sciences
(80)
Medical Sciences
(73)
Adolescent
(72)
Child, Preschool
(64)
Adult
(60)
Hematologic And Hematopoietic Diseases
(48)
Infant
(45)
Pediatrics
(45)
Young Adult
(39)
Middle Aged
(38)
Oncology
(30)
Anemias. Hemoglobinopathies
(27)
Diseases Of Red Blood Cells
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions

Erythrocyte pyruvate kinase deficiency: 2015 status report

Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study

Pediatric Heparin-Induced Thrombocytopenia: Prevalence, Thrombotic Risk, and Application of the 4Ts Scoring System

Safety update on the use of recombinant activated factor VII in approved indications

Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol

Systematic molecular genetic analysis of congenital sideroblastic anemia: Evidence for genetic heterogeneity and identification of novel mutations

Risk of Post-Procedural Bleeding in Children on Intravenous Fish Oil

Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion

Novel therapeutics and future directions for refractory immune thrombocytopenia

Does iron overload really matter in stem cell transplantation?

X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation

Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families: Observations from the Dosing Observational Study in Hemophilia

Inadequate Dietary Intake in Patients with Thalassemia

Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension

Treatment with Rituximab in Benign and Malignant Hematologic Disorders in Children

MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients

Beliefs about chelation among thalassemia patients

Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Observational Study in Hemophilia (DOSE)

Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP

A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload

Skin Testing, Graded Challenge and Desensitization to Von Willebrand Factor (vWF) Products in Type III Von Willebrand Disease (VWD)

Inflammation and oxidant-stress in β-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine : an ancillary study of the Novartis CICL670A0107 trial

Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results

Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)

Suchergebnisse filtern